Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
Top Cited Papers
- 1 January 2010
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 103 (06), 1116-1127
- https://doi.org/10.1160/th09-11-0758
Abstract
Thrombosis and Haemostasis publishes original basic research and clinical studies in vascular biology and medicine, serving as an international platform for dissemination and debate of scientific information at the cutting edge.Keywords
This publication has 29 references indexed in Scilit:
- Management of major bleedings during anticoagulant treatment with the oral direct thrombin inhibitor ximelagatran or warfarinBlood Coagulation & Fibrinolysis, 2009
- Effect of Recombinant Activated Factor VII in Critical Bleeding: Clinical Experience of a Single CenterClinical and Applied Thrombosis/hemostasis, 2009
- The Complexity of and Opportunity for Screening in Primary CareAnnals of Family Medicine, 2009
- Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agentsBlood, 2008
- The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjectsBritish Journal of Clinical Pharmacology, 2007
- In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilateThrombosis and Haemostasis, 2007
- Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysisBritish Journal of Clinical Pharmacology, 2006
- Impact of Bleeding Severity on Clinical Outcomes Among Patients With Acute Coronary SyndromesThe American Journal of Cardiology, 2005
- AbstractsJournal of Thrombosis and Haemostasis, 2005
- The Ecarin Clotting Time, a Universal Method to Quantify Direct Thrombin InhibitorsPathophysiology of Haemostasis and Thrombosis, 2003